About: Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1997 (uk) im November 1997 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1997 (en) artículu científicu espublizáu en payares de 1997 (ast)
publication date	wds:Q73877940-D2F45D45-B8D1-4DE7-A158-FC74D53D2E01
publication date	1997-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73877940-A1F16459-C9E8-4210-A7AE-0CD9425E3101
language of work or name	English
rdfs:label	Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (en) Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (nl)
skos:prefLabel	Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (en) Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (nl)
name	Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (en) Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (nl)
title	wds:Q73877940-9CA446FC-16CF-458F-BE3B-9A84844932C2
title	Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group (en)
page(s)	wds:Q73877940-8853DB29-2D42-4876-B46C-3E441F41162E
page(s)	2109-2118
instance of	wds:Q73877940-460D1823-38B3-475C-A34F-74B07349D83B
instance of	scholarly article
PubMed ID	wds:Q73877940-CEE7DB6C-9CB8-40A2-B1D4-2F85749B76D4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9368550
PubMed ID	9368550
published in	wds:Q73877940-DC80632D-586F-4B93-BCBB-33B32F7864FF
published in	Stroke Journal
issue	wds:Q73877940-3A1FA7A0-09B0-4FB8-885F-1AF1DD928247
volume	wds:Q73877940-42771908-8F97-456F-A453-C2EE01C9E3E3
issue	11
volume	28
DOI	wds:Q73877940-C0B4D82D-747C-44D1-A157-8378CA2BE88E
DOI	http://dx.doi.org/10.1161/01.STR.28.11.2109
DOI	10.1161/01.STR.28.11.2109
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73877940
is cites work of	Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications Ultrasound enhanced thrombolysis in acute arterial ischemia. Hyperacute management of ischemic stroke Thrombolysis for acute ischaemic stroke Cerebral hemorrhagic complications of thrombolytic therapy Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment Triggers, targets and treatments for thrombosis Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Cytoprotective protein C pathways and implications for stroke and neurological disorders Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Will molecular optical imaging have clinically important roles in stroke management, and how? Thrombolysis for acute ischaemic stroke Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score Monitoring cerebral oxygenation during balloon occlusion with multichannel NIRS. Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model Variability in the Perception of Informed Consent for IV-tPA during Telestroke Consultation Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions Thrombolysis for acute stroke: is it for everyone? Thrombolysis for acute ischaemic stroke Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas Intracerebral hemorrhage Noncontrast conventional computed tomography in the evaluation of acute stroke siRNA Treatment: "A Sword-in-the-Stone" for Acute Brain Injuries Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation Breaking the barrier in stroke: what should we know? A mini-review. Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets. Hemorrhage rates and outcomes when using up to 100 mg intra-arterial t-PA for thrombolysis in acute ischemic stroke Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice Quantitative evaluation of BBB permeability after embolic stroke in rat using MRI. Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management Extension of the thrombolytic time window with minocycline in experimental stroke. Triggers and mediators of hemorrhagic transformation in cerebral ischemia Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100 Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Diagnosis as a guide to stroke therapy. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke Intra-arterial thrombolysis for carotid circulation ischemia Thrombolytic treatment of acute cerebral infarction Equipoise among recanalization strategies Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497. Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke Views on the use of tissue plasminogen activator in acute ischemic stroke: a state-wide survey among neurologists and emergency medicine physicians in Indiana Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software